Security key
03237H101
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)
CUSIP: 03237H101
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 110,465,093
- Total 13F shares
- 73,877,500
- Share change
- +24,094,275
- Total reported value
- $261,528,744
- Put/Call ratio
- 58%
- Price per share
- $3.54
- Number of holders
- 134
- Value change
- +$85,099,354
- Number of buys
- 80
- Number of sells
- 46
Report period
Q1 2025
Institutions
134
Top holders
10
AMLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Amylyx Pharmaceuticals, Inc. SEC filings
Amylyx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03237H101
Recent filing periods:
Ownership snapshot
Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Panacea Innovation Ltd
13D/G signal
Panacea Innovation Ltd
Evidence rows
50
Latest as of
31 Dec 2024
13D/G
13F
Lead comparable stake: 2.6%
13D/G row: Panacea Innovation Ltd
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Panacea Innovation Ltd |
13D/G
Panacea Venture Healthcare Fund II, L.P.
|
2.6%
|
$11,792,000
2,200,000 shares
|
$0 | 31 Dec 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
6.1%
|
$25,607,035
6,774,348 shares
|
— | 31 Dec 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
4.2%
|
$17,553,609
4,643,812 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.4%
|
$10,177,608
2,692,489 shares
|
— | 31 Dec 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
2.2%
|
$9,171,274
2,426,263 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
2.1%
|
$8,614,370
2,278,934 shares
|
— | 31 Dec 2024 |
| Almitas Capital LLC |
13F
Company
|
1.8%
|
$7,682,359
2,032,370 shares
|
— | 31 Dec 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.8%
|
$7,449,261
1,970,704 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
134
Shares
73,877,500
Rows loaded
136
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
120
Q1 2025 holders
134
Holder diff
14
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend